Funding Rounds
VRG Therapeutics

VRG Therapeutics Series A (2023, $5M)

VRG Therapeutics

Biotech R&D specializing in miniprotein-based pharmaceuticals and cellular & gene therapy (CGT) products

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $5.48M

Investors